Signpost Capital Advisors, LP
Follow13F filer, CIK 1560812, New York, NY
Signpost Capital Advisors, LP reported $118,858,000 across 12 holdings for the quarter ended 2016-09-30, in a 13F-HR filed 2016-11-10. Its ten largest share positions make up 96.08% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001560812-16-000024
Changes against Q2 2016 are not shown: its report omitted holdings under a confidential treatment request (12 positions on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2016-09-30
- Reported value
- $119M
- Holdings
- 12
- Top 10 weight
- 96.08%
- New
- Sold out
Holdings, Q3 2016
Share positions as resolved from 13F-HR 0001560812-16-000024, largest first. % of portfolio is the value over $118,858,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| KRAFT HEINZ COKRAFT HEINZ CO | 380,000 | $34M | 28.62% | The filing omitted confidential holdings, a later amendment may add them. | |||
| CALPINE CORPCALPINE CORP | 1,962,463 | $24.8M | 20.87% | The filing omitted confidential holdings, a later amendment may add them. | |||
| AMZNAMAZON COM INC | 12,325 | $10.3M | 8.68% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| CALPINE CORPCALPINE CORP | 812,100 | $10.3M | 8.64% | The filing omitted confidential holdings, a later amendment may add them. | |||
| SRGSERITAGE GROWTH PPTYS | 173,072 | $8.77M | 7.38% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| PROTO LABS INCPROTO LABS INC | 113,000 | $6.77M | 5.7% | The filing omitted confidential holdings, a later amendment may add them. | |||
| DVADAVITA INC | 88,900 | $5.87M | 4.94% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| MEDICINES COMEDICINES CO | 151,356 | $5.71M | 4.81% | The filing omitted confidential holdings, a later amendment may add them. | |||
| RETROPHIN INCRETROPHIN INC | 203,141 | $4.55M | 3.82% | The filing omitted confidential holdings, a later amendment may add them. | |||
| ALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INC | 46,000 | $3.12M | 2.62% | The filing omitted confidential holdings, a later amendment may add them. | |||
| OPHTHOTECH CORPOPHTHOTECH CORP | 50,587 | $2.33M | 1.96% | The filing omitted confidential holdings, a later amendment may add them. | |||
| ALNYALNYLAM PHARMACEUTICALS INC | 34,365 | $2.33M | 1.96% | The filing omitted confidential holdings, a later amendment may add them. | Timeline |
How Q3 2016 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001560812-16-000024 | base | 2016-11-10 | acceptance time not in the bulk data set |